APA

Schlenk R. F., Fröhling S., Hartmann F., Fischer J. T., Glasmacher A., del Valle F., Grimminger W., Götze K., Waterhouse C., Schoch R., Pralle H., Mergenthaler H. G., Hensel M., Koller E., Kirchen H., Preiss J., Salwender H., Biedermann H. G., Kremers S., Griesinger F., Benner A., Addamo B., Döhner K., Haas R. & Döhner H. (20041202). Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. : Leukemia.

Chicago

Schlenk R F, Fröhling S, Hartmann F, Fischer J Th, Glasmacher A, del Valle F, Grimminger W, Götze K, Waterhouse C, Schoch R, Pralle H, Mergenthaler H G, Hensel M, Koller E, Kirchen H, Preiss J, Salwender H, Biedermann H G, Kremers S, Griesinger F, Benner A, Addamo B, Döhner K, Haas R and Döhner H. 20041202. Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. : Leukemia.

Harvard

Schlenk R. F., Fröhling S., Hartmann F., Fischer J. T., Glasmacher A., del Valle F., Grimminger W., Götze K., Waterhouse C., Schoch R., Pralle H., Mergenthaler H. G., Hensel M., Koller E., Kirchen H., Preiss J., Salwender H., Biedermann H. G., Kremers S., Griesinger F., Benner A., Addamo B., Döhner K., Haas R. and Döhner H. (20041202). Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. : Leukemia.

MLA

Schlenk R F, Fröhling S, Hartmann F, Fischer J Th, Glasmacher A, del Valle F, Grimminger W, Götze K, Waterhouse C, Schoch R, Pralle H, Mergenthaler H G, Hensel M, Koller E, Kirchen H, Preiss J, Salwender H, Biedermann H G, Kremers S, Griesinger F, Benner A, Addamo B, Döhner K, Haas R and Döhner H. Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. : Leukemia. 20041202.